Literature DB >> 31567914

Analysis of Periorbital Soft Tissue in Thyroid Eye Disease.

Masashi Mimura1,2, Patrick T Yang1, Audrey C Ko1, Bobby S Korn1,3, Don O Kikkawa1,3.   

Abstract

PURPOSE: To investigate periorbital tissue enlargement in thyroid eye disease (TED) by 3-dimensional CT volumetric analysis.
METHODS: Twenty-four adult subjects, 16 with TED and 8 controls, were studied. Three-dimensional volumetric calculations were performed on CT imaging of the orbit and face, focusing on the retroorbicularis oculi fat, suborbicularis oculi fat, facial muscles in periorbital region, orbital fat, extraocular muscles, and orbital volume. Analysis was performed using JMP version 12 software. Each measure was compared between the TED and control groups using Wilcoxon rank sum test. Correlations were investigated between periorbital and orbital tissue using the Spearman's correlation coefficient method.
RESULTS: A statistically significant increase in volume was measured in TED patients in the superior and inferior periorbital fat tissue (p = 0.0044, p = 0.047), including the retroorbicularis oculi fat (p = 0.0011), suborbicularis oculi fat (p = 0.0093), and a decrease in facial muscle of superior periorbital region (p = 0.035). Strong positive correlation was noted between the muscles of superior and inferior periorbital region (rs = 0.65; p = 0.0006), and between the suborbicularis oculi fat and retroorbicularis oculi fat (rs = 0.50; p = 0.013). No correlation was observed between orbital and periorbital tissue, except between the orbital fat and the inferior periorbital fat tissue (p = 0.047).
CONCLUSIONS: Facial fat in the periorbital region is enlarged in TED, with the superior component correlating with orbital fat tissue expansion. These findings may assist in the clinical evaluation and management of disfigurement in TED patients.Superior and inferior periorbital fat is enlarged in thyroid eye disease with the superior periorbital fat expansion correlating with orbital fat expansion.

Entities:  

Mesh:

Year:  2020        PMID: 31567914     DOI: 10.1097/IOP.0000000000001450

Source DB:  PubMed          Journal:  Ophthalmic Plast Reconstr Surg        ISSN: 0740-9303            Impact factor:   1.746


  2 in total

1.  Risk prediction of dysthyroid optic neuropathy based on CT imaging features combined the bony orbit with the soft tissue structures.

Authors:  Shengnan Cheng; Yangcan Ming; Mang Hu; Yan Zhang; Fagang Jiang; Xinghua Wang; Zefeng Xiao
Journal:  Front Med (Lausanne)       Date:  2022-08-24

2.  Early experience with teprotumumab for chronic thyroid eye disease.

Authors:  Daniel J Ozzello; Don O Kikkawa; Bobby S Korn
Journal:  Am J Ophthalmol Case Rep       Date:  2020-05-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.